MIV-247
/ Medivir
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 15, 2020
Inhibition of cathepsin S attenuates myocardial ischemia/reperfusion injury by suppressing inflammation and apoptosis.
(PubMed, J Cell Physiol)
- "These abovementioned changes were blocked by two different selective cathepsin S inhibitors, LY3000328 or MIV-247. Moreover, Kaplan-Meier survival plot showed that cathepsin S inhibition improved 21-day survival rate following myocardial I/R injury. This study demonstrated that the inhibition of cathepsin S alleviated myocardial I/R-induced injury by suppressing inflammation and apoptosis, which may be used in clinical applications of cardioprotection."
Journal • Cardiovascular • Gene Therapies • Immunology • Ischemic stroke • Myocardial Ischemia • Reperfusion Injury • CASP3 • CASP8 • IL6 • TNFA • TNNI3
1 to 1
Of
1
Go to page
1